ClearPoint Neuro, Inc.CLPTNASDAQ

Revenue (LTM)

$37M

+17.8% YoY

Net Income (LTM)

$-26M

-35.0% YoY

Free Cash Flow

$-24M

Revenue CAGR (5Y)

+23.6%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	16	21↑26.1%	24↑16.6%	31↑31.0%	37↑17.8%
Gross Profit	11	14↑21.6%	14↑0.6%	19↑40.5%	23↑18.7%
Operating Income	-13	-16↓22.1%	-22↓37.4%	-20↑12.0%	-24↓22.4%
Net Income	-14	-16↓14.1%	-22↓34.4%	-19↑14.4%	-26↓35.0%
EBITDA	-13	-16↓22.2%	-21↓34.7%	-18↑15.0%	-24↓35.4%
EPS Diluted	-0.69	-0.68↑1.4%	-0.90↓32.4%	-0.70↑22.2%	-0.90↓28.6%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	54	28↓49.0%	23↓16.2%	20↓13.1%	46↑128.4%
Total Current Assets	62	51↓17.3%	36↓29.3%	33↓7.8%	64↑90.6%
Total Assets	66	55↓15.4%	43↓23.1%	39↓8.1%	98↑149.4%
Total Current Liabilities	5	7↑42.8%	7↑9.5%	10↑39.3%	11↑4.0%
Total Liabilities	17	19↑10.8%	21↑15.5%	14↓35.8%	70↑405.3%
Total Equity	49	37↓24.4%	21↓42.6%	25↑19.9%	28↑10.4%
Total Debt	12	12↓2.4%	14↑16.3%	4↓74.4%	58↑1532.1%
Net Debt	-42	-16↑62.6%	-9↑41.1%	-17↓79.8%	12↑174.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-13	-16↓27.3%	-14↑15.1%	-9↑34.8%	-24↓167.3%
Capital Expenditure	-0	-0↓50.6%	-1↓183.4%	-0↑61.6%	-1↓89.8%
Free Cash Flow	-13	-16↓27.6%	-14↑12.1%	-9↑36.1%	-24↓165.0%
Stock-Based Comp	2	0	6	7↑13.6%	8↑18.4%
Net Change in Cash	34	-26↓177.9%	-4↑83.1%	-3↑32.2%	27↑985.0%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance